Houston, Texas
United States
9
2026-02-19
3
2025-10-28
These are the the leading inventors for applications assigned to MULTIVIR INC.:
MULTIVIR INC. based in Houston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER
#2 | 2024-02-08METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY FOR THE INHIBITION OF PATHOGENS
#3 | 2022-07-21METHODS AND COMPOSITIONS COMPRISING ENHANCED TARGETED IMMUNE GENE THERAPY FOR THE TREATMENT OF CANCER
#4 | 2021-04-01 ✅ Patent 12,454,561 granted on 2025-10-28METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER
#5 | 2021-03-25P53 BIOMARKERS
#6 | 2020-01-09METHODS AND COMPOSITIONS COMPRISING VIRAL GENE THERAPY AND AN IMMUNE CHECKPOINT INHIBITOR FOR TREATMENT AND PREVENTION OF CANCER AND INFECTIOUS DISEASES
#7 | 2019-02-07COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND IMMUNE CHECKPOINT BLOCKADE FOR THE TREATMENT OF CANCER
#8 | 2018-06-07 ✅ Patent 10,883,993 granted on 2021-01-05P53 biomarkers
#9 | 2011-04-28 ✅ Patent 9,746,471 granted on 2017-08-29P53 biomarkers
Also check out MULTIVIR INC.'s (Houston, United States) applicant profile with 3 patent applications submitted.
135885 ⎘